These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15890422)
1. Proton beam therapy: too expensive to become true? Lievens Y; Van den Bogaert W Radiother Oncol; 2005 May; 75(2):131-3. PubMed ID: 15890422 [No Abstract] [Full Text] [Related]
2. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan. Nakagawa Y; Yoshihara H; Kageji T; Matsuoka R; Nakagawa Y Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S80-3. PubMed ID: 19394238 [TBL] [Abstract][Full Text] [Related]
4. The potential of proton beam radiation therapy in head and neck cancer. Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595 [TBL] [Abstract][Full Text] [Related]
5. The potential of proton beam radiation therapy in breast cancer. Björk-Eriksson T; Glimelius B Acta Oncol; 2005; 44(8):884-9. PubMed ID: 16332597 [TBL] [Abstract][Full Text] [Related]
6. The potential of proton beam therapy in paediatric cancer. Björk-Eriksson T; Glimelius B Acta Oncol; 2005; 44(8):871-5. PubMed ID: 16332594 [TBL] [Abstract][Full Text] [Related]
7. Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed. Schulz RJ; Smith AR; Orton CG Med Phys; 2007 Apr; 34(4):1135-8. PubMed ID: 17500444 [No Abstract] [Full Text] [Related]
8. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Johansson B; Ridderheim M; Glimelius B Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598 [TBL] [Abstract][Full Text] [Related]
9. The promise of protons in cancer therapy. Macready N J Natl Cancer Inst; 2012 May; 104(9):648-9. PubMed ID: 22517986 [No Abstract] [Full Text] [Related]
10. Technology evolution: is it survival of the fittest? Zietman A; Goitein M; Tepper JE J Clin Oncol; 2010 Sep; 28(27):4275-9. PubMed ID: 20697074 [TBL] [Abstract][Full Text] [Related]
11. Number of patients potentially eligible for proton therapy. Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591 [TBL] [Abstract][Full Text] [Related]
12. [Which equipment for proton therapy of the future?]. Schwartz LH; Laisne A; Ivanov AA; Mandrillon P; Chauvel P; Mazal A; Habrand JL; Tronc D; Baccal M; Laugier A Bull Cancer Radiother; 1995; 82(4):365-9. PubMed ID: 8554889 [TBL] [Abstract][Full Text] [Related]
13. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800 [TBL] [Abstract][Full Text] [Related]
14. [The cost of radiotherapy]. Martin P Bull Cancer; 2003 Nov; 90(11):969-75. PubMed ID: 14706900 [TBL] [Abstract][Full Text] [Related]
15. No holding back. Report unlikely to slow demand for proton therapy. Rhea S Mod Healthc; 2009 Sep; 39(38):12. PubMed ID: 19810231 [No Abstract] [Full Text] [Related]